-
PTC Therapeutics' (PTCT) Outperform Rating Reiterated at Robert W. Baird
Источник: Buzz FX / 08 окт 2024 14:06:09 America/Chicago
PTC Therapeutics' (PTCT) Outperform Rating Reiterated at Robert W. Baird Written by MarketBeat October 8, 2024 Share Link copied to clipboard. PTC Therapeutics ( NASDAQ:PTCT - Get Free Report ) 's stock had its "outperform" rating reiterate
Read more...